Heidi Hagen

Insider Reports History

Location
Ann Arbor, MI
Signature
/s/ Sean Flynn, as Attorney-in-Fact for Heidi Hagen
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Heidi Hagen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Vericel Corp Director Common Stock 31,850 $1,421,147 $44.62 30 Apr 2025 Direct
Vericel Corp Director Restricted Stock Unit 3,200 $57,600 $18.00 01 May 2024 Direct
ZIOPHARM ONCOLOGY INC Director Common Stock 145,889 $20,468 $0.1403 02 Sep 2021 Direct
Vericel Corp Director Stock Option (Right to Buy) 8,000 30 Apr 2025 Direct
Vericel Corp Director Restricted Stock Unit 3,200 30 Apr 2025 Direct

Insider Reports Filed by Heidi Hagen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VCEL Vericel Corp 30 Apr 2025 4 $0 4 Director 02 May 2025, 16:07
VCEL Vericel Corp 03 Mar 2025 3 -$412,110 4 Director 05 Mar 2025, 16:05
VCEL Vericel Corp 17 Oct 2024 4 +$37,400 4 Director 21 Oct 2024, 16:05
VCEL Vericel Corp 01 May 2024 4 $0 4 Director 03 May 2024, 16:06
VCEL Vericel Corp 03 May 2023 2 $0 4 Director 05 May 2023, 16:05
VCEL Vericel Corp 27 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:04
VCEL Vericel Corp 27 Apr 2022 4 $0 4 Director 29 Apr 2022, 16:03
TCRT ZIOPHARM ONCOLOGY INC 02 Sep 2021 1 +$41,835 4 Director 03 Sep 2021, 17:25
VCEL Vericel Corp 19 May 2021 6 +$34,860 4 Director 20 May 2021, 16:10